Correction: Dendritic cell therapy augments antitumor immunity triggered by CDK4/6 inhibition and immune checkpoint blockade by unleashing systemic CD4 T-cell responses

Benzer Materyaller

• EPO Receptor Blockade in Dendritic Cells Enhances Antitumor CD8+ T Cell Immunity
  Yazar:: Yunfei Zhu, ve diğerleri
  Baskı/Yayın Bilgisi: (2026-01-01)
• ERα blockade in dendritic cells enhances antigen cross-presentation and induces antitumor CD8+ T cell immunity
  Yazar:: Yaxin Liu, ve diğerleri
  Baskı/Yayın Bilgisi: (2026-05-01)
• Regulatory T cells in immune checkpoint blockade antitumor therapy
  Yazar:: An Zhang, ve diğerleri
  Baskı/Yayın Bilgisi: (2024-11-01)
• Expression of c-erb-B2 oncoprotein as a neoantigen strategy to repurpose anti-neu antibody therapy in a model of melanoma
  Yazar:: Emmanuel M. Gabriel, ve diğerleri
  Baskı/Yayın Bilgisi: (2024-10-01)
• Correction: Dendritic cell therapy augments antitumor immunity triggered by CDK4/6 inhibition and immune checkpoint blockade by unleashing systemic CD4 T-cell responses
  Baskı/Yayın Bilgisi: (2023-06-01)